These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32138474)

  • 1. Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement.
    Hur KY; Kim MK; Ko SH; Han M; Lee DW; Kwon HS; ; ;
    Kidney Res Clin Pract; 2020 Mar; 39(1):32-39. PubMed ID: 32138474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement.
    Hur KY; Kim MK; Ko SH; Han M; Lee DW; Kwon HS; ;
    Diabetes Metab J; 2020 Feb; 44(1):3-10. PubMed ID: 32097995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations-consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM).
    Orlacchio A; Guastoni C; Beretta GD; Cosmai L; Galluzzo M; Gori S; Grassedonio E; Incorvaia L; Marcantoni C; Netti GS; Passamonti M; Porta C; Procopio G; Rizzo M; Roma S; Romanini L; Stacul F; Casinelli A
    Radiol Med; 2022 May; 127(5):534-542. PubMed ID: 35303246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin: time to review its role and safety in chronic kidney disease.
    Tanner C; Wang G; Liu N; Andrikopoulos S; Zajac JD; Ekinci EI
    Med J Aust; 2019 Jul; 211(1):37-42. PubMed ID: 31187887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
    Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
    J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
    Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function markers and metformin eligibility.
    Tavares Bello C; Castro Fonseca R; Sousa Santos F; Sequeira Duarte J; Azinheira J; Vasconcelos C
    Minerva Endocrinol; 2018 Sep; 43(3):246-252. PubMed ID: 28565889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine.
    Tuot DS; Lin F; Shlipak MG; Grubbs V; Hsu CY; Yee J; Shahinian V; Saran R; Saydah S; Williams DE; Powe NR;
    Diabetes Care; 2015 Nov; 38(11):2059-67. PubMed ID: 26307607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prescribing metformin according to eGFR instead of serum creatinine level: A study based on Korean National Health and Nutrition Examination Survey (KNHANES) 2009-2014.
    Moon SJ; Ahn CH; Cho YM
    PLoS One; 2017; 12(4):e0175334. PubMed ID: 28399132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.
    Wang J; Ai X; Li L; Gao Y; Sun N; Li C; Sun W
    Int Urol Nephrol; 2017 Nov; 49(11):2019-2026. PubMed ID: 28656510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.
    Lazarus B; Wu A; Shin JI; Sang Y; Alexander GC; Secora A; Inker LA; Coresh J; Chang AR; Grams ME
    JAMA Intern Med; 2018 Jul; 178(7):903-910. PubMed ID: 29868840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin.
    Warren RE; Strachan MW; Wild S; McKnight JA
    Diabet Med; 2007 May; 24(5):494-7. PubMed ID: 17367305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin initiation and renal impairment: a cohort study in Denmark and the UK.
    Christiansen CF; Ehrenstein V; Heide-Jørgensen U; Skovbo S; Nørrelund H; Sørensen HT; Li L; Jick S
    BMJ Open; 2015 Sep; 5(9):e008531. PubMed ID: 26338686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of metformin in patients with chronic kidney disease stage 4 and metformin-naïve type 2 diabetes.
    Dissanayake AM; Wheldon MC; Hood CJ
    Pharmacol Res Perspect; 2018 Oct; 6(5):e00424. PubMed ID: 30221006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease.
    Hsu WH; Hsiao PJ; Lin PC; Chen SC; Lee MY; Shin SJ
    Oncotarget; 2018 Jan; 9(4):5416-5423. PubMed ID: 29435189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C measurement leads to lower metformin dosage in elderly type 2 diabetic patients.
    Šálek T; Adamíková A
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):298-302. PubMed ID: 30218617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactic acidosis due to metformin in type 2 diabetes mellitus and chronic kidney disease stage 3-5: is it significant?
    Prabhu RA; Mareddy AS; Nagaraju SP; Rangaswamy D; Guddattu V
    Int Urol Nephrol; 2019 Jul; 51(7):1229-1230. PubMed ID: 30963454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of serum creatinine and kidney function among incident metformin users.
    Schorr M; Hemmelgarn BR; Tonelli M; Soo A; Manns BJ; Bresee LC;
    Can J Diabetes; 2013 Aug; 37(4):226-230. PubMed ID: 24070885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!
    Kalantar-Zadeh K; Kovesdy CP
    Diabetes Care; 2016 Jul; 39(7):1281-6. PubMed ID: 27330129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.